Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would guess that better liquidity would attract a few more traders and hopefully more investors
But do you think it will create a lot more flippers in the market?
Asking for a friend!
I mean I would like to be able to sell a stock and buy another the next day, but I am a novice to a lot of this.
First order of business is to release the
10-Q by the 15th. That should tell us a lot
Not saying it will happen, but they blindsided us with the last one and then didn’t say a word about it after they did it. They have run this whole thing super sketchy since day 1.. so who knows what they are going to do
I like the idea of the one day settlement period
If the transaction can be settled in one day, give me my money!
Does that eliminate the potential for good faith violations if only one buy and one sell is completed each day?
The trade settlement period will be shortened to one day beginning May 28, 2024.
What are some of your guys' thoughts and opinions?
I'm kinda mixed on it. I can see both sides of the argument.
I like hearing (reading) others' thoughts. Go....
Looking forward to it
So wish it would happen even 2 dollar gain and we’re still wayyyy down
You bet I am. 100,000 share day in RXMD will move this a couple dollars. The share float is very small.
Is the market anticipating a good quarterly?
Your previous post talked about falling share price and R/S. That's what I responded to.
Well , the company unusual quiet and shows no eager to rise hope makes us feel that way ...normal shareholders should have the same concern, right ?
color - PPS has been moving up the last few days. Why do a couple of you keep mentioning a RS that will never happen.
It would be pretty easy for someone to slowly buy up RXMD shares and then run up NXPL shares to gain that leverage as we approach Q results.
Why buy RXMD for 2.30 when NXPL is at 1.20 and you only get 1.48 shares for each RXMD? Unless you think the deal will change or fall through for something better?
Quiet as always ,so the pps lower and lower , hopefully they are not plan to RS us again.
All truths will be revealed via the quarterly. I am waiting with clenched cheeks.
All the scoops have melted under Charlie's lack of leadership and much to be desired communication.
Whats the inside scoop?
Idk Cabin, I believe we all might be surprised this time.
Good luck to all of us.
Rephrase…. Another Q of something that keep us from being g profitable.
Likely another Q of disappointment.
Take care
You too my friend
Hopefully it's a good one
Q next week
We might see then. Fingers crossed 🤞
Can we get anything to confirm management still has a pulse? Everything I read tells me this company will be successful, besides the daily share price… In for the long haul with RXMD!
There's a little action today. Maybe fernandez placed that discreet tmall order.
Never Ending Story!! Certainly a classic Turbo. Even Atreyu knew when to walk away as Artax began sinking into the Swamp of Sadness tar pits.
Fernandez hosed A LOT of investors on both sides of the NXPL / RXMD coin.
You're telling me. I'm living it.
The never ending story - nostalgic
The never ending quiet period- nightmarish
Yikes! That sounds worse than a 3 year quiet period 😬
I hope the merger comes with a loud period!
Good Luck RXMD shareholders!
Good Luck NXPL shareholders!
$RXMD + $NXPL
He meant funball. It's a game you play behind the Wendy's dumpster.
Hey, What is Finbull?
Good Luck RXMD shareholders!
Good Luck NXPL shareholders!
$RXMD + $NXPL
I’ve been buying small amounts each week. It adds up.
Hey Mike! How is Finbull
I'll be adding another 1500 tomorrow.
HaHa...Bingo!!
Up sizing your extra value meal
Everything looks great! 2.8 million shares will get gobbled up fast on 100,000 volume days.
Such a small Public Float. You're right...this would jump so quickly.
Sure wished Mark Cuban would buy those shares up. Can you imagine how much this would fly? ( I know it's just wishful thinking, but wow).
Hopefully in the morning time
Followers
|
746
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
194446
|
Created
|
01/09/11
|
Type
|
Free
|
Moderators gedi8 Truth022809 stockforce TrackDude MrMike241 |
Progressive Care Gains SEC Reporting Status
See on website
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
The effective Form 10 obligates the Company to file Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, in addition to complying with all other obligations under the Exchange Act. In addition, management and certain shareholders are subject to the beneficial ownership reporting requirements of Section 13 and 16 of the Exchange Act.
Alan Jay Weisberg, Chairman and Chief Executive Officer of the Company said, “For me, it was always important to have the Company become fully reporting with the SEC. I know how critical it is for individual and institutional investors to have the Company file its financial reports with the SEC as it provides a higher level of confidence in the information reported by the Company and a superior level of transparency. I believe that the Company’s compliance with the Exchange Act will ultimately help drive shareholder value and enable us to access higher quality institutional capital. We remain committed to strong corporate governance and steadfast in pursuit of our journey to Nasdaq.”
To view the Form 10 filling, please click:
https://www.sec.gov/Archives/edgar/data/0001402945/000149315222009357/form10-12ga.htm
Key Financial Highlights for Year Ended December 31, 2021
• Revenue at $38.9 million
- COVID-19 testing revenue of approximately $4.3 million
- ClearMetrX TPA and pharmacy dispensing revenue related to 340B earned $2.8 million on total billings of $19 million
• Gross margin increased to 26% in 2021, from 23% in 2020
• EBITDA increased to $167,000 in 2021 from $7,000 in 2020
• Cash balance of $1.4 million as of December 31, 2021
Business Highlights for the Year Ended December 31, 2021
• Re-implemented upgraded pharmacy software system
• Expanded COVID-19 business into corporate-focused services and institutional clients
• Strengthened reputation in the 340B sector by adding eight new contracts
• Filed initial S-1 registration statement
• Submitted application for uplisting to Nasdaq
Q4 2021 Reflected a Positive Bounce Back in Business
• Increase of 10% in prescription revenue to $8.9 million in the fourth quarter of 2021, from $8.1 million in the third quarter of 2021
• Increase of 8% in prescriptions filled to 114,000 in the fourth quarter of 2021, from 106,000 in the third quarter of 2021
PRODUCTS AND SERVICES
Advances in HIV/AIDS treatment has greatly increased the ability of those suffering from the disease to manage their symptoms and live longer, healthier lives. Effective management of the disease begins with taking the right medications with the right dose at the right times. For those in the HIV/AIDS community, adhering to the very strict dietary and medicinal requirements can be extremely difficult. Normal activities are often interrupted and sometimes prevented by the struggle to be in compliance.
PharmCo wants to ease this burden on those impacted by this life altering disease. We aim to make compliance with prescription regiments as easy as possible. By understanding the sensitive nature of HIV/AIDS and the needs of those afflicted, PharmCo provides the following services to patients with these special needs:
1. Confidential packaging
2. Packaging tailored to suit a patient's individual life style
3. Free delivery from a variety of sources including PharmCo's proprietary delivery fleet
4. A staff that is well trained in acute illnesses, who understands the patient's needs and
concerns
5. 24 hour emergency support
6. Timely availability of specialty medications due to our extensive inventory
7. Access to newly developed medications
PharmCo is a fully accredited DME supplier. In November 2010, as part of Medicare's competitive bidding, PharmCo was awarded a three year contract to supply hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories in South Florida. PharmCo carries an extensive inventory of equipment and accessories with most special requests being honored with same day or next day delivery. The company offers both sales and rentals with size, color, style, and brand options available on the majority of products. Most importantly, the staff is knowledgeable, helpful and dedicated to providing superior customer service.
PharmCo offers home service and maintenance, defective product replacements, and free home installation and instruction.
PharmCo's institutional clients have come to depend on the company's proven accuracy, dispensing methods, and immediate response time. With PharmCo compliance and efficiency assistance, long term care institutions are able to provide the highest level of continued care to their patients. PharmCo provides purchasing, repackaging and dispensing of both prescription and non-prescription pharmaceutical products. PharmCo utilizes a unit-of-dose packaging system as opposed to traditional vials used for its retail customers. This method of distribution improves control and patient compliance with recommended drug therapy by increasing the timeliness and accuracy of medication dispensing. PharmCo also provides computerized maintenance of patient prescription histories, third party billing and consultant pharmacist services. Its consulting services consist primarily of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system.
Long term care institutions can count on PharmCo for the following services:
1. On time, same day deliveries available twice a day with 24 hour emergency support
2. Language assistance in English, Spanish, French, Creole, Portuguese, Russian, and Hebrew
3. Unit-dose packaging options tailored the facility's needs
4. Prescription data accuracy
5. Extensive medication and DME inventory
6. Access to OTC medications, nutritional products and personal hygiene items
7. Provision and review of medication carts
8. Monthly pharmacy consultations- drug interactions, redundant therapies, side effects, etc.
9. Compliance updates and consultations
10. Staff Training
11. Exceptional customer service.
Toll Free: 888-919-7411 Phone: 305-919-7399 Fax: 305-919-7424
HOURS
Monday- Thursday 8:30 AM - 6:30 PM
Friday 8:30 AM - 6:00 PM
Saturday 11:00 AM - 4:00 PM
PharmCo currently services: Miami-Dade, Broward, Palm Beach, Martin, and St. Lucie Counties.
Progressive Care Reports Full Year 2021 Financial Results Highlighted by $38.9 Million in RevenueGLOBENEWSWIRE – 11:16 AM ET 03/29/2022 |
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in ChinaGLOBENEWSWIRE – 7:00 AM ET 02/02/2022
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |